Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

3 Stocks to Buy From the ‘Buy the Dip’ ETF

By Will Ashworth, InvestorPlace Contributor
It’s a lot harder than it looks to buy the dip. Using artificial intelligence to do this makes these three stocks a buy.

Why Is LumiraDx (LMDX) Stock Up 323% Today?

By William White, InvestorPlace Writer
LumiraDx stock is rising higher on Monday with heavy trading of LMDX shares after announcing a partnership with AstraZeneca.

3 Healthcare Stocks to Invest in for a Big Shot of Gains

By Joel Baglole, InvestorPlace Contributor
Most healthcare stocks are down across the board. Pharma companies, health insurers, and medical device manufacturers have all seen their share prices decline. That said, there are a few stocks that have managed to separate themselves from the pack with new innovations and strong financial results.

7 Under-the-Radar Growth Stocks Ready to Make a Splash

By Louis Navellier and the InvestorPlace Research Staff
By being involved in some of the most creative industries, these growth stocks help you capitalize on emerging trends and technologies.

7 Biotech Stocks to Get In Now Before Investors Catch On

By John Blankenhorn, InvestorPlace Contributor
Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them.

Tilray Stock’s Tumble: A Buying Opportunity or a Cautionary Tale?

By Chris MacDonald, InvestorPlace Contributor
The cannabis sector is one that's been absolutely crushed of late. Can investors in Tilray and TLRY stock make it out ahead?

7 Healthcare Stocks to invest in for a Healthy Future

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
Healthcare stocks may be one of the few winning sectors considering today's economic uncertainty and market turns. Here are the winners.

Why Is Xortx Therapeutics (XRTX) Stock Up 110% Today?

By William White, InvestorPlace Writer
Xortx Therapeutics stock is on the rise Friday with heavy trading of XRTX shares despite a lack of news from the pharmaceutical company.

7 Dividend Stocks to Buy and Hold Forever and Ever

By Alex Sirois, InvestorPlace Contributor
Investors must consider long-term dividend stocks to buy for their safety as markets remain turbulent in mid-October.

7 Healthcare Stocks That Can Cure a Lackluster Portfolio

By Joel Baglole, InvestorPlace Contributor
Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio.

Make Rite Aid a Meme Stock at Your Own Risk

By Samuel O'Brient, InvestorPlace Reporter
After declaring bankruptcy, Rite Aid has surged on meme stock momentum. Here's why that still doesn't make it a buy.

Why Is Spectral AI (MDAI) Stock Up 61% Today?

By William White, InvestorPlace Writer
Spectral AI stock is taking off on Thursday with heavy trading as MDAI investors celebrate an update on a device from the company.

7 Stocks to Buy and Hold for a Lifetime of Wealth

By Louis Navellier and the InvestorPlace Research Staff
The best way to live a stress-free life and build wealth in the long term is to choose stocks to buy and hold. Here are seven that fit the bill.

Stocks to Sell: 7 Overbought Companies You Ought to Dump Right Now

By Rick Orford, InvestorPlace Contributor
Overbought stocks are an early indication of a potential correction on a stock; act now if you hold these stocks.

7 Dividend Aristocrats That Are Built to Last

By Thomas Niel, InvestorPlace Contributor
For dependability and durability, take a closer look at these seven dividend stocks, all of which hold aristocratic status.

The Pros Got It Wrong: 3 Stocks to Sell Despite Recent Upgrades

By Chris Markoch, InvestorPlace Contributor
These three stocks to sell may be good picks for nimble traders, but for long-term investors, it may be time to put them aside.

The Next Trillion-Dollar Companies: 3 Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor
The spotlight is on these three next trillion-dollar companies expected to continue growing at a rapid pace.

3 Gene Editing Stocks to Generate Super-Charged Gains

By Ian Cooper, InvestorPlace Contributor
As things progress, such techniques may be able to knock out every disease known, creating massive opportunity for gene-editing stocks.

FDA Sends ARDX Stock Soaring After Approving Ardelyx’s Kidney Disease Drug

By Larry Ramer, InvestorPlace Contributor
ARDX stock is rallying after the U.S. Food and Drug Administration (FDA) approved Ardelyx's kidney disease treatment.
Load More Articles